النرويج - النرويجية - Statens legemiddelverk

ge healthcare b.v. - fludeoksyglukose (18f) - injeksjonsvæske, oppløsning - 250 mbq/ ml

النرويج - النرويجية - Statens legemiddelverk

cis bio international - butedronatetetranatrium - preparasjonssett til radioaktive legemidler - 13 mg

النرويج - النرويجية - Statens legemiddelverk

curium netherlands b.v. - kalsiumtrinatriumpentetat - preparasjonssett til radioaktive legemidler

الاتحاد الأوروبي - النرويجية - EMA (European Medicines Agency)

novartis europharm limited - ruxolitinib (som fosfat) - myeloproliferative disorders; polycythemia vera; graft vs host disease - antineoplastiske midler - myelofibrosis (mf)jakavi is indicated for the treatment of disease related splenomegaly or symptoms in adult patients with primary myelofibrosis (also known as chronic idiopathic myelofibrosis), post polycythaemia vera myelofibrosis or post essential thrombocythaemia myelofibrosis. polycythaemia vera (pv)jakavi er indisert for behandling av voksne pasienter med polycythaemia vera som er resistente mot eller intolerante av hydroxyurea. graft versus host disease (gvhd)jakavi is indicated for the treatment of patients aged 12 years and older with acute graft versus host disease or chronic graft versus host disease who have inadequate response to corticosteroids or other systemic therapies (see section 5.

الاتحاد الأوروبي - النرويجية - EMA (European Medicines Agency)

pharmathen s.a. - memantinhydroklorid - alzheimers sykdom - psychoanaleptics, , andre anti-demens legemidler - behandling av pasienter med moderat til alvorlig alzheimers sykdom.

الاتحاد الأوروبي - النرويجية - EMA (European Medicines Agency)

nova laboratories ireland limited - spironolakton - edema; heart failure; liver cirrhosis; ascites; nephrotic syndrome; hyperaldosteronism; essential hypertension - antihypertensives and diuretics in combination - in the management of refractory oedema associated with congestive cardiac failure; hepatic cirrhosis with ascites and oedema, malignant ascites, nephrotic syndrome, diagnosis and treatment of primary aldosteronism, essential hypertension. neonates, children and adolescents should only be treated under guidance of a paediatric specialist (see sections 5. 1 og 5.

النرويج - النرويجية - Statens legemiddelverk

ge healthcare as - albumin humant serum makroaggregater ad tc-99m makroalbumin - pulver til injeksjonsvæske, suspensjon

النرويج - النرويجية - Statens legemiddelverk

curium netherlands b.v. - jobenguansulfat (123i) - injeksjonsvæske, oppløsning - 74 mbq/ ml

النرويج - النرويجية - Statens legemiddelverk

ge healthcare b.v. - jobenguansulfat (123i) - injeksjonsvæske, oppløsning - 74 mbq/ ml

النرويج - النرويجية - Statens legemiddelverk

ge healthcare ltd - krom (51cr) edetat - injeksjonsvæske, oppløsning - 3.7 mbq/ ml